Tirosh Itay, Venteicher Andrew S, Hebert Christine, Escalante Leah E, Patel Anoop P, Yizhak Keren, Fisher Jonathan M, Rodman Christopher, Mount Christopher, Filbin Mariella G, Neftel Cyril, Desai Niyati, Nyman Jackson, Izar Benjamin, Luo Christina C, Francis Joshua M, Patel Aanand A, Onozato Maristela L, Riggi Nicolo, Livak Kenneth J, Gennert Dave, Satija Rahul, Nahed Brian V, Curry William T, Martuza Robert L, Mylvaganam Ravindra, Iafrate A John, Frosch Matthew P, Golub Todd R, Rivera Miguel N, Getz Gad, Rozenblatt-Rosen Orit, Cahill Daniel P, Monje Michelle, Bernstein Bradley E, Louis David N, Regev Aviv, Suvà Mario L
Broad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA.
Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA.
Nature. 2016 Nov 10;539(7628):309-313. doi: 10.1038/nature20123. Epub 2016 Nov 2.
Although human tumours are shaped by the genetic evolution of cancer cells, evidence also suggests that they display hierarchies related to developmental pathways and epigenetic programs in which cancer stem cells (CSCs) can drive tumour growth and give rise to differentiated progeny. Yet, unbiased evidence for CSCs in solid human malignancies remains elusive. Here we profile 4,347 single cells from six IDH1 or IDH2 mutant human oligodendrogliomas by RNA sequencing (RNA-seq) and reconstruct their developmental programs from genome-wide expression signatures. We infer that most cancer cells are differentiated along two specialized glial programs, whereas a rare subpopulation of cells is undifferentiated and associated with a neural stem cell expression program. Cells with expression signatures for proliferation are highly enriched in this rare subpopulation, consistent with a model in which CSCs are primarily responsible for fuelling the growth of oligodendroglioma in humans. Analysis of copy number variation (CNV) shows that distinct CNV sub-clones within tumours display similar cellular hierarchies, suggesting that the architecture of oligodendroglioma is primarily dictated by developmental programs. Subclonal point mutation analysis supports a similar model, although a full phylogenetic tree would be required to definitively determine the effect of genetic evolution on the inferred hierarchies. Our single-cell analyses provide insight into the cellular architecture of oligodendrogliomas at single-cell resolution and support the cancer stem cell model, with substantial implications for disease management.
尽管人类肿瘤是由癌细胞的基因进化塑造而成,但有证据表明,它们还呈现出与发育途径和表观遗传程序相关的层级结构,其中癌症干细胞(CSC)可驱动肿瘤生长并产生分化后代。然而,在实体人类恶性肿瘤中,CSC的无偏证据仍然难以捉摸。在这里,我们通过RNA测序(RNA-seq)对来自6例异柠檬酸脱氢酶1(IDH1)或异柠檬酸脱氢酶2(IDH2)突变型人类少突胶质细胞瘤的4347个单细胞进行了分析,并从全基因组表达特征重建了它们的发育程序。我们推断,大多数癌细胞沿着两种特化的神经胶质程序分化,而一小部分罕见的细胞亚群未分化且与神经干细胞表达程序相关。具有增殖表达特征的细胞在这个罕见的亚群中高度富集,这与一种模型一致,即CSC主要负责推动人类少突胶质细胞瘤的生长。拷贝数变异(CNV)分析表明,肿瘤内不同的CNV亚克隆显示出相似的细胞层级结构,这表明少突胶质细胞瘤的结构主要由发育程序决定。亚克隆点突变分析支持类似的模型,尽管需要完整的系统发育树来明确确定基因进化对推断层级结构的影响。我们的单细胞分析在单细胞分辨率上深入了解了少突胶质细胞瘤的细胞结构,并支持癌症干细胞模型,这对疾病管理具有重要意义。